Concord Medical Co., Ltd. (TPEX:6518)

Market Cap	1.05B +23.5%
Revenue (ttm)	964.35M +8.4%
Net Income	67.36M +35.9%
EPS	2.01 +35.8%
Shares Out	33.33M
PE Ratio	15.70
Forward PE	n/a
Dividend	1.50 (4.90%)
Ex-Dividend Date	Apr 10, 2026

Volume	5,495
Open	31.55
Previous Close	31.55
Day's Range	31.35 - 31.55
52-Week Range	25.40 - 53.60
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About Concord Medical

Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment pl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6518

Financial Performance

In 2025, Concord Medical's revenue was 964.35 million, an increase of 8.37% compared to the previous year's 889.85 million. Earnings were 67.36 million, an increase of 35.90%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error